Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
0.6640
+0.0096 (1.47%)
At close: Jan 23, 2026, 4:00 PM EST
0.6507
-0.0133 (-2.00%)
After-hours: Jan 23, 2026, 7:17 PM EST
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $7.11 million as of January 23, 2026. Its market cap has decreased by -30.30% in one year.
Market Cap
7.11M
Enterprise Value
-3.61M
1-Year Change
-30.30%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $7.11M, an increase of 42.95%. That is a compound annual growth rate of 2.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 7.11M | 1.57% |
| Dec 31, 2025 | 7.00M | -36.83% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 6.79M |
| Bio Green Med Solution | 6.79M |
| Genprex | 6.76M |
| Silexion Therapeutics | 6.72M |
| Adial Pharmaceuticals | 6.49M |
| Acurx Pharmaceuticals | 6.48M |
| Alaunos Therapeutics | 6.47M |
| Xenetic Biosciences | 6.37M |